Feed Insights Top Reports Pricing

⌘K

13:05:22·2d

SECFilingvia Quantisnow

SEC Form 10-Q filed by MPLX LP

ByQuantisnow·Wall Street's wire, on your screen.

Energy

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MPLX (MPLX LP) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

MPLX
MPLX LP
Energy

Recent analyst ratings

Mar 24UpdateTruist$67.00
Jan 5UpdateRaymond James-
Dec 1UpdateAnalyst$57.00
Oct 17UpdateBofA Securities$43.00
Oct 6UpdateGoldman$40.00
Mar 14UpdateJP Morgan$41.00

Related

SEC20h
SEC Form S-3ASR filed by MPLX LP
SEC2d
MPLX LP filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
PR2d
MPLX LP Reports First-Quarter 2026 Financial Results
INSIDER2d
Director Walker Ray N Jr was granted 2,247 units of Common Units, increasing direct ownership by 129% to 3,991 units (SEC Form 4)
INSIDER2d
Director Surma John P was granted 2,580 units of Common Units, increasing direct ownership by 3% to 91,770 units (SEC Form 4)
INSIDER2d
Director Stice J Michael was granted 2,580 units of Common Units, increasing direct ownership by 5% to 55,875 units (SEC Form 4)
INSIDER2d
Director Semple Frank M was granted 2,580 units of Common Units, increasing direct ownership by 4% to 60,752 units (SEC Form 4)
INSIDER2d
Director Peiffer Garry L. was granted 2,247 units of Common Units, increasing direct ownership by 4% to 66,319 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022